Search

Your search keyword '"Jonathan Messika"' showing total 52 results

Search Constraints

Start Over You searched for: Author "Jonathan Messika" Remove constraint Author: "Jonathan Messika" Topic pulmonary and respiratory medicine Remove constraint Topic: pulmonary and respiratory medicine
52 results on '"Jonathan Messika"'

Search Results

1. A 24-Year-Old Woman With Cough, Arthralgia, and Skin Ulcerations

3. The Effect of an Accelerated Renal Replacement Therapy Initiation Is Not Modified by Baseline Risk

4. Characteristics and Outcomes of Patients in the ICU With Respiratory Syncytial Virus Compared With Those With Influenza Infection

5. Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease

6. Outcome of Lung Transplantation Using Grafts From Donors Over 65 Years of Age

8. Primary spontaneous pneumothorax: French guidelines are ready for launching!

9. SPLF/SMFU/SRLF/SFAR/SFCTCV Guidelines for the management of patients with primary spontaneous pneumothorax

10. Outcome of acute hypoxaemic respiratory failure: insights from the LUNG SAFE Study

11. Favorable, arduous or fatal postoperative pathway within 90 days of lung transplantation

12. Prevalence, Intensity, and Clinical Impact of Dyspnea in Critically Ill Patients Receiving Invasive Ventilation

13. High-Flow Versus VenturiMask Oxygen Therapy to Prevent Reintubation in Hypoxemic Patients after Extubation: A Multicenter Randomized Clinical Trial

14. Patient-important outcomes in lung transplantation: A systematic review

15. Efficacy of three COVID-19 vaccine doses in lung transplant recipients: a multicentre cohort study

16. Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G

17. Lung transplantation for COVID-19-associated ARDS

18. Clinical assessment of scannographic markers for sarcopenia in lung transplant candidates

19. Antiplatelet Drugs and Risk of Bleeding After Bedside Pleural Procedures: A National Multicenter Cohort Study

20. An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy

21. Objective structured clinical examinations (OSCEs) for students’ training and assessment in the French respiratory medicine departments in 2021: An overview

22. Microbiological testing of adults hospitalised with community-acquired pneumonia: an international study

23. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

24. Outpatient management of primary spontaneous pneumothorax

25. Résultats précoces de la transplantation pulmonaire chez les patients âgés de 65 ans et plus

26. Infinitix-BOS Trial: Multi-Center, Randomised, Double-Blind Placebo-Controlled Trial of Nintedanib in Lung Transplant Recipients with Bronchiolitis Obliterans Syndrome (BOS) Grade 0-p and Grade 1-2

27. Airway Complications in Lung Transplant Recipients with Telomere-Related Interstitial Lung Disease

28. High-Flow Nasal Oxygen Therapy Outside the Intensive Care Setting: How Safe Is Safe Enough?

29. Risques associés à la prise d’anti-inflammatoires non stéroïdiens au cours de la pneumonie

30. Underreporting of End-of-Life Decisions in Critical Care Trials: A Call to Modify the Consolidated Standards of Reporting Trials Statement

31. Coping strategies, anxiety and depression related to the COVID-19 pandemic in lung transplant candidates and recipients. Results from a monocenter series

32. Essai multicentrique, randomisé double aveugle contre placebo, évaluant l’efficacité du Nintedanib dans le traitement du syndrome de bronchiolite oblitérante grade 0-p et grade 1-2 chez les patients transplantés pulmonaires

33. Progression rapide de la fibrose du poumon natif associée à une infection virale sévère après transplantation monopulmonaire pour fibrose

34. Pseudomonas aeruginosa eradication after lung transplantation: is it the tip of the iceberg?

35. Longer symptom onset to aspiration time predicts success of needle aspiration in primary spontaneous pneumothorax

36. Infections à Corynébactéries non diphtériques et complications bronchiques après transplantation pulmonaire – une étude cas-témoin

37. Quels sont les critères de jugements importants pour le patient en transplantation pulmonaire ? Une revue systématique de la littérature

38. Antifibrosants: risque post-opératoire chez les patients transplantés pour une fibrose pulmonaire idiopathique

39. High-flow nasal oxygen for bronchoalveolar lavage in acute respiratory failure patients

40. Increased use of high-flow nasal oxygen during bronchoscopy

41. Tranexamic Acid Inhalations in Nonmassive Hemoptysis

42. A musical intervention for respiratory comfort during noninvasive ventilation in the ICU

43. Low-dose corticosteroids during severe community-acquired pneumonia: end of the story

44. The Challenging Diagnosis of Non-Community-Acquired Pneumonia in Non-Mechanically Ventilated Subjects: Value of Microbiological Investigation

45. Nonsteroidal anti-inflammatory drugs in community-acquired pneumonia

46. Use of High-Flow Nasal Cannula Oxygen Therapy in Subjects With ARDS: A 1-Year Observational Study

47. Risque hémorragique des gestes pleuraux sous antiagrégants plaquettaires : étude multicentrique et prospective

48. Quels déterminants du succès primaire de l’exsufflation de pneumothorax spontané ?

Catalog

Books, media, physical & digital resources